Evidence map›Paper›PMID 21619929›Full record

ReviewFree radical biology & medicine2011

Inorganic nitrite therapy: historical perspective and future directions.

Christopher G Kevil, Gopi K Kolluru, Christopher B Pattillo, Tony Giordano

Open access · greenAbstract readReview
In one paragraph

Review in Free radical biology & medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 110 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Knockdown of Salusin-Oxidative medicine and cellular longevity · 2021
    Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Gasotransmitter Heterocellular Signaling.Antioxidants & redox signaling · 2017
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Christopher G KevilDepartment of Pathology, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA 71130, USA. ckevil@lsuhsc.edu
Gopi K Kolluru
Christopher B Pattillo
Tony Giordano
Louisiana State University Health Sciences Center Shreveport · US

Funding

VASCULAR REACTIVITY FOLLOWING ISCHEMIA-REPERFUSIONP01DK043785 · NIDDK · LOUISIANA STATE UNIV HSC SHREVEPORT · PI GRANGER, D. NEIL · 1991 to 2011
$17.0M
ICAM-1 governs angiogenesis and endothelial redox statusR01HL080482 · NHLBI · LOUISIANA STATE UNIV HSC SHREVEPORT · PI KEVIL, CHRISTOPHER G · 2006 to 2010
$1.8M
GCL-M Regulation of AngiogenesisF32HL094021 · NHLBI · LOUISIANA STATE UNIV HSC SHREVEPORT · PI PATTILLO, CHRISTOPHER BRUCE · 2008 to 2010
$149k
NHLBI NIH HHS F32 HL094021NHLBI NIH HHS HL094021NHLBI NIH HHS HL80482NHLBI NIH HHS R01 HL080482NIDDK NIH HHS DK043785NIDDK NIH HHS P01 DK043785
6 · The paper itself

Abstract

Over the past several years, investigators studying nitric oxide (NO) biology and metabolism have come to learn that the one-electron oxidation product of NO, nitrite anion, serves as a unique player in modulating tissue NO bioavailability. Numerous studies have examined how this oxidized metabolite of NO can act as a salvage pathway for maintaining NO equivalents through multiple reduction mechanisms in permissive tissue environments. Moreover, it is now clear that nitrite anion production and distribution throughout the body can act in an endocrine manner to augment NO bioavailability, which is important for physiological and pathological processes. These discoveries have led to renewed hope and efforts for an effective NO-based therapeutic agent through the unique action of sodium nitrite as an NO prodrug. More recent studies also indicate that sodium nitrate may also increase plasma nitrite levels via the enterosalivary circulatory system resulting in nitrate reduction to nitrite by microorganisms found within the oral cavity. In this review, we discuss the importance of nitrite anion in several disease models along with an appraisal of sodium nitrite therapy in the clinic, potential caveats of such clinical uses, and future possibilities for nitrite-based therapies.

Indexed as

AnimalsAutoimmune DiseasesBacteriaHumansInflammationInorganic ChemicalsIschemiaMouthNeoplasmsNitric OxideOxidation-ReductionSodium NitriteInorganic ChemicalsNitric OxideSodium Nitrite

Identifiers

PMID21619929
PMCPMC4414241
OpenAlexW2075903936

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.